Follow the 루닛 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 루닛 has published 24 reports. Market capitalisation: €737.1bn. The latest transaction was filed on 8 May 2026 (Purchase). Among the most active insiders: 백승욱. Every trade is openly available.
24
Insider Decl.
n/a
Thresholds
€61m
23 ops.
Buy Volume
€1m
1 ops.
Sell Volume
30Σ signal
Buys €61m€1m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,153 of 29,063 companies
28.4
score / 100
Value
19
Quality
38
FCF yld-8.3%
Earn yld-6.0%
EV/EBITDA·
ROE-24%
Gross mgn100%
Net mgn-57%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
루닛 es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se centra en el desarrollo de soluciones de inteligencia artificial para diagnósticos médicos.